Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Nov 17;7(12):e794. doi: 10.1097/TXD.0000000000001246

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2021 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.

PMC Copyright notice

FIGURE 2. — SARS-CoV-2–specific humoral immunity elicited by the mRNA-1273 vaccine in SOT recipients: (A) proportion of patients with IgG antibodies targeting the SARS-CoV-2 S protein assessed by commercial ELISA at baseline, after the first vaccine dose vaccine, and at 2 wk after the completion of the vaccine series; (B) proportion with serum neutralizing activity against the S protein analyzed with an in-house hACE-2/spike antibody inhibition ELISA-based method at the same time points. Comparisons between repeated measures were performed with the Wilcoxon signed-rank test. hACE, human angiotensin-converting enzyme; IgG, immunoglobulin; S, SARS-CoV-2 spike glycoprotein; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2; SOT, solid organ transplantation.